ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2019.0.227 2019.0.227 2020-03-312020-03-311313true2019-04-01falsetruetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 06230037 2019-04-01 2020-03-31 06230037 2018-04-01 2019-03-31 06230037 2020-03-31 06230037 2019-03-31 06230037 2018-04-01 06230037 c:Director1 2019-04-01 2020-03-31 06230037 d:Buildings d:ShortLeaseholdAssets 2019-04-01 2020-03-31 06230037 d:Buildings d:ShortLeaseholdAssets 2020-03-31 06230037 d:Buildings d:ShortLeaseholdAssets 2019-03-31 06230037 d:MotorVehicles 2019-04-01 2020-03-31 06230037 d:MotorVehicles 2020-03-31 06230037 d:MotorVehicles 2019-03-31 06230037 d:MotorVehicles d:OwnedOrFreeholdAssets 2019-04-01 2020-03-31 06230037 d:FurnitureFittings 2019-04-01 2020-03-31 06230037 d:FurnitureFittings 2020-03-31 06230037 d:FurnitureFittings 2019-03-31 06230037 d:FurnitureFittings d:OwnedOrFreeholdAssets 2019-04-01 2020-03-31 06230037 d:ComputerEquipment 2019-04-01 2020-03-31 06230037 d:ComputerEquipment 2020-03-31 06230037 d:ComputerEquipment 2019-03-31 06230037 d:ComputerEquipment d:OwnedOrFreeholdAssets 2019-04-01 2020-03-31 06230037 d:OwnedOrFreeholdAssets 2019-04-01 2020-03-31 06230037 d:CurrentFinancialInstruments 2020-03-31 06230037 d:CurrentFinancialInstruments 2019-03-31 06230037 d:CurrentFinancialInstruments d:WithinOneYear 2020-03-31 06230037 d:CurrentFinancialInstruments d:WithinOneYear 2019-03-31 06230037 d:ShareCapital 2020-03-31 06230037 d:ShareCapital 2019-03-31 06230037 d:RetainedEarningsAccumulatedLosses 2020-03-31 06230037 d:RetainedEarningsAccumulatedLosses 2019-03-31 06230037 c:OrdinaryShareClass1 2019-04-01 2020-03-31 06230037 c:OrdinaryShareClass1 2020-03-31 06230037 c:FRS102 2019-04-01 2020-03-31 06230037 c:AuditExempt-NoAccountantsReport 2019-04-01 2020-03-31 06230037 c:FullAccounts 2019-04-01 2020-03-31 06230037 c:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31 06230037 d:WithinOneYear 2020-03-31 06230037 d:WithinOneYear 2019-03-31 06230037 d:BetweenOneFiveYears 2020-03-31 06230037 d:BetweenOneFiveYears 2019-03-31 06230037 2 2019-04-01 2020-03-31 06230037 d:AcceleratedTaxDepreciationDeferredTax 2020-03-31 06230037 d:AcceleratedTaxDepreciationDeferredTax 2019-03-31 06230037 d:OtherDeferredTax 2020-03-31 06230037 d:OtherDeferredTax 2019-03-31 06230037 d:ShareCapitalOtherShareTypes 2020-03-31 06230037 d:ShareCapitalOtherShareTypes 2019-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 06230037














PETTS WOOD PHARMACY LIMITED

 
UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2020

 
PETTS WOOD PHARMACY LIMITED
 

CONTENTS



Page
Balance sheet
 
1 - 2
Notes to the financial statements
 
3 - 8


 
PETTS WOOD PHARMACY LIMITED
REGISTERED NUMBER:06230037

BALANCE SHEET
AS AT 31 MARCH 2020

2020
2019
Note
£
£

Fixed assets
  

Tangible assets
 4 
30,379
40,556

  
30,379
40,556

Current assets
  

Stocks
 5 
203,709
230,843

Debtors: amounts falling due within one year
 6 
2,620,735
2,759,580

Cash at bank and in hand
 7 
1,412,101
831,707

  
4,236,545
3,822,130

Creditors: amounts falling due within one year
 8 
(497,697)
(429,703)

Net current assets
  
 
 
3,738,848
 
 
3,392,427

Total assets less current liabilities
  
3,769,227
3,432,983

Provisions for liabilities
  

Deferred tax
 9 
(2,117)
(2,957)

  
 
 
(2,117)
 
 
(2,957)

Net assets
  
3,767,110
3,430,026


Capital and reserves
  

Called up share capital 
 10 
4
4

Profit and loss account
  
3,767,106
3,430,022

  
3,767,110
3,430,026


1

 
PETTS WOOD PHARMACY LIMITED
REGISTERED NUMBER:06230037
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2020

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 September 2020.




D Tanna
Director

The notes on pages 3 to 8 form part of these financial statements.

2

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

1.


General information

Petts Wood Pharmacy Limited is a private company, limited by shares, registered in England and Wales, registration number 06230037. The registered office address is Elsley Court, 20-22 Great Titchfield Street, London, W1W 8BE and the trading address is Orchard Lodge Farm, 118 The Heath, East Malling, Kent, ME19 6JL.
The principal activity of the company continued to be that of a pharmacy.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The company's functional and presentational currency is pound sterling.

The following principal accounting policies have been applied:

 
2.2

Going concern

The directors are assessing, on a daily basis, the impact of the significant uncertainty arising from the COVID-19 virus. Whilst the directors appreciate there is significant uncertainty surrounding the future economic climate, they consider the pharmaceutical industry to be particularly robust in this current situation and demand for the specific products the company supplies continues to increase. Despite the company experiencing what the directors consider to be short term supply issues, the strong financial position of the company will allow time to determine and implement any changes required through decisions of the board of directors and the rising demand for company products is expected to realise turnover and profitability gains in the foreseeable future. The directors are therefore satisfied that the company will be able to satisfy its financial obligations for at least 12 months from the date of signature of the financial statements, which have been prepared on the going concern basis.

 
2.3

Turnover

Turnover from pharmacy is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

3

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method and on a reducing balance basis.

Depreciation is provided on the following basis:

Short term Leasehold Property
-
7%
on a straight line basis
Motor vehicles
-
25%
reducing balance basis
Fixtures and fittings
-
25%
reducing balance basis
Computer equipment
-
33%
on a straight line basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a weighted averagebasis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.6

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.8

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties and loans to related parties.

 
2.9

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

 Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the lease term.

4

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

2.Accounting policies (continued)

 
2.11

 Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the company in independently administered funds.

 
2.12

 Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.13

 Provisions for liabilities

Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the company becomes aware of the obligation, and are measured at the best estimate at the Balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

 
2.14

 Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

5

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

3.


Employees

The average monthly number of employees, including directors, during the year was 13 (2019 - 13).


4.


Tangible fixed assets





Short term Leasehold Property
Motor vehicles
Fixtures and fittings
Computer equipment
Total

£
£
£
£
£



Cost or valuation


At 1 April 2019
9,337
19,425
260,300
6,798
295,860



At 31 March 2020

9,337
19,425
260,300
6,798
295,860



Depreciation


At 1 April 2019
6,999
12,230
229,277
6,798
255,304


Charge for the year on owned assets
622
1,799
7,756
-
10,177



At 31 March 2020

7,621
14,029
237,033
6,798
265,481



Net book value



At 31 March 2020
1,716
5,396
23,267
-
30,379



At 31 March 2019
2,338
7,195
31,023
-
40,556




The net book value of land and buildings may be further analysed as follows:


2020
2019
£
£

Short leasehold
1,716
2,338



5.


Stocks

2020
2019
£
£

Finished goods and goods for resale
203,709
230,843


6

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

6.


Debtors

2020
2019
£
£


Trade debtors
212,670
290,186

Amounts owed by group undertakings
2,357,803
2,416,253

Other debtors
35,182
37,958

Prepayments
15,080
15,183

2,620,735
2,759,580



7.


Cash and cash equivalents

2020
2019
£
£

Cash at bank and in hand
1,412,101
831,707



8.


Creditors: Amounts falling due within one year

2020
2019
£
£

Trade creditors
341,579
301,956

Corporation tax
81,808
91,515

Other taxation and social security
901
-

Other creditors
55,620
30,616

Accruals
17,789
5,616

497,697
429,703


A company in the group has a bank loan which are secured by a fixed and floating charge over the assets of the group by right of a cross guarantee.


9.


Deferred taxation




2020
2019


£

£






At beginning of year
(2,957)
(4,053)


Charged to profit or loss
840
1,096



At end of year
(2,117)
(2,957)

7

 
PETTS WOOD PHARMACY LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020
 
9.Deferred taxation (continued)

The provision for deferred taxation is made up as follows:

2020
2019
£
£


Accelerated capital allowances
(2,223)
(2,989)

Short term timing differences
106
32

(2,117)
(2,957)


10.


Share capital

2020
2019
£
£
Allotted, called up and fully paid



4 Ordinary shares of £1.00 each
4
4


11.


Pension commitments

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £26,416 (2019 - £32,003). At the balance sheet date the company owed £557 (2019 - £187) to the pension fund. 


12.


Commitments under operating leases

At 31 March 2020 the company had future minimum lease payments under non-cancellable operating leases as follows:

2020
2019
£
£


Not later than 1 year
18,500
17,300

Later than 1 year and not later than 5 years
32,375
47,575

50,875
64,875


13.


Related party transactions

At the year end, the company owed £48,239 (2019 - £25,318) to the directors. These are interest free loans and repayable on demand.
No disclosure has been made of transactions with other wholly owned group companies in accordance with FRS 102 section 1A paragraph 1AC.35, as the company is itself a wholly owned subsidiary of Interactive London Limited. 

 
8